Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Aug 9;8:354. doi: 10.1038/s41420-022-01125-y

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 4 — A Box plot showing the differential FTO mRNA levels in normal and tumor samples. B Differential analysis of FTO levels in normal and tumor samples based on GSE81809 dataset. C Differential analysis of FTO levels in normal and tumor samples based on GSE68465 dataset. D–F Correlation analysis showing the underlying relationships between FTO levels and clinical phenotypes, including TP53-mutation status (D), lymphatic metastasis (E) and clinicalpathological stages (F). G–H Kaplan–Meier analysis with log-rank test showed that patients with low FTO had poorer OS outcomes relative to those with high FTO expressions based on TCGA-LUAD cohort (G) and combined pan-LUAD datasets (H). Bar = Mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001.